ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,385Medicare Part D Prescriptions Filled, Including Refills

Rank: 255 out of 1383

$395K Total Retail Price of All Prescriptions

Rank: 502 out of 1383

343 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 343 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

25% of this provider’s 343 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

4% of this provider’s 8,608 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$35 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
HYDROCODONE-ACETAMINOPHEN 549 370 S3 1 1
POTASSIUM CHLORIDE 463 397 2 12
LISINOPRIL 430 360 3 3
FUROSEMIDE 393 326 4 7
LEVOTHYROXINE SODIUM 388 313 5 4
METOPROLOL TARTRATE 343 272 6 9
HYDROCHLOROTHIAZIDE 288 248 7 10
AMLODIPINE BESYLATE 263 237 8 6
OMEPRAZOLE 258 191 9 5
TRAMADOL HCL 233 169 10 25
GABAPENTIN 232 183 11 11
GLYBURIDE 173 138 R 12 46
SERTRALINE HCL 135 83 13 21
CLONIDINE HCL 133 120 14 44
FAMOTIDINE 133 87 14 61
ZOLPIDEM TARTRATE 132 37 16 17
SIMVASTATIN 129 94 17 2
MELOXICAM 129 104 17 20
TRAZODONE HCL 106 76 19 36
PAROXETINE HCL 106 52 19 55
OXYCODONE HCL-ACETAMINOPHEN 105 72 S2 21 81
ALLOPURINOL 103 95 22 33
PANTOPRAZOLE SODIUM 102 70 23 32
METFORMIN HCL 100 79 24 8
NEXIUM 98 62 25 26
RISPERIDONE 95 89 26 71
OXYCODONE-ACETAMINOPHEN 92 83 S2 27 107
LOVASTATIN 90 86 28 22
METHYLPREDNISOLONE 89 62 29 133
CYCLOBENZAPRINE HCL 84 68 R 30 69
PROMETHAZINE HCL 83 56 R 31 56
CEPHALEXIN 83 55 31 87
RANITIDINE HCL 82 26 33 19
SPIRONOLACTONE 79 47 34 67
CARVEDILOL 76 60 35 24
CARISOPRODOL 74 0 R 36 76
KLOR-CON M20 70 62 37 100
PLAVIX 70 61 37 43
CLOPIDOGREL 67 50 39 28
WARFARIN SODIUM 65 51 40 13
JANTOVEN 65 65 40 146
DIGOXIN 62 56 42 59
CITALOPRAM HBR 61 50 43 15
PROCRIT 60 60 44 309
BUSPIRONE HCL 59 54 45 109
ENALAPRIL MALEATE 57 45 46 75
LEVOFLOXACIN 54 31 47 88
CEFUROXIME 54 42 47 164
ATENOLOL 53 53 49 16
AMITRIPTYLINE HCL 51 0 R 50 57
CIPROFLOXACIN HCL 51 45 50 54
MECLIZINE HCL 50 41 52 113
SULFAMETHOXAZOLE-TRIMETHOPRIM 50 35 52 89
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.